Zavadáková Petra, Fowler Brian, Suormala Terttu, Novotna Zorka, Mueller Peter, Hennermann Julia B, Zeman Jirí, Vilaseca M Antonia, Vilarinho Laura, Gutsche Sven, Wilichowski Ekkehard, Horneff Gerd, Kozich Viktor
Institute of Inherited Metabolic Diseases, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Hum Mutat. 2005 Mar;25(3):239-47. doi: 10.1002/humu.20131.
The cblE type of homocystinuria is a rare autosomal recessive disorder caused by impaired reductive activation of methionine synthase. Although earlier biochemical studies proposed that the methionine synthase enzyme might be activated by two different reducing systems, mutations were reported in only the methionine synthase reductase gene (MTRR) in cblE patients. The pathogenicity of MTRR mutations, however, has not yet been tested functionally. We report on nine patients of European origin affected by the cblE type of homocystinuria. They presented between 2 weeks and 3 years of age (median age 4 weeks) with anemia, which was macrocytic in only three patients, and with neurological involvement in all but two cases. Bone marrow examination performed in seven patients showed megaloblastic changes in all but one of them. All patients exhibited moderate to severe hyperhomocysteinemia (median plasma total homocysteine [Hcy] 92 mumol/L, range 44-169), while clearly reduced methionine was observed only in four cases. Pathogenic mutations were identified in both parental alleles of the MTRR gene in all patients. Five known (c.903+469T>C, c.1361C>T, c.1459G>A, c.1557-4_1557+3del7, and c.1622_1623dupTA) and three novel mutations (c.7A>T, c.1573C>T, and c.1953-6_1953-2del5) were detected. Importantly, transfection of fibroblasts of cblE patients with a wild-type MTRR minigene expression construct resulted in a significant approximately four-fold increase of methionine synthesis, indicating correction of the enzyme defect. Our study shows a link between a milder predominantly hematological presentation and homozygosity for the c.1361C>T mutation, but no other obvious genotype-phenotype correlation. The identification of mutations in the MTRR gene, together with restoration of methionine synthesis following MTRR minigene expression in cblE cells confirms that this disease is caused by defects in the MTRR gene.
同型胱氨酸尿症的cblE型是一种罕见的常染色体隐性疾病,由甲硫氨酸合成酶的还原性激活受损引起。尽管早期的生化研究表明甲硫氨酸合成酶可能由两种不同的还原系统激活,但在cblE患者中仅报道了甲硫氨酸合成酶还原酶基因(MTRR)的突变。然而,MTRR突变的致病性尚未经过功能测试。我们报告了9例欧洲血统的cblE型同型胱氨酸尿症患者。他们在2周龄至3岁之间发病(中位年龄4周),表现为贫血,仅3例为大细胞性贫血,除2例之外均有神经受累。7例患者进行的骨髓检查显示,除1例之外其余均有巨幼细胞改变。所有患者均表现为中度至重度高同型半胱氨酸血症(血浆总同型半胱氨酸[Hcy]中位值92μmol/L,范围44 - 169),而仅4例观察到甲硫氨酸明显降低。在所有患者的MTRR基因的两个亲本等位基因中均鉴定出致病突变。检测到5种已知突变(c.903 + 469T>C、c.1361C>T、c.1459G>A、c.1557 - 4_1557 + 3del7和c.1622_1623dupTA)以及3种新突变(c.7A>T、c.1573C>T和c.1953 - 6_1953 - 2del5)。重要的是,用野生型MTRR小基因表达构建体转染cblE患者的成纤维细胞导致甲硫氨酸合成显著增加约4倍,表明酶缺陷得到纠正。我们的研究显示了较轻微的主要血液学表现与c.1361C>T突变纯合性之间的联系,但未发现其他明显的基因型 - 表型相关性。MTRR基因中突变的鉴定,以及cblE细胞中MTRR小基因表达后甲硫氨酸合成的恢复,证实了该疾病是由MTRR基因缺陷引起的。